CANOPY GROWTH CORP (WEED.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:WEED - CA1380357048 - Common Stock
2.53 CAD
+0.23 (+10%)
Taking everything into account, WEED scores 2 out of 10 in our fundamental rating. WEED was compared to 30 industry peers in the Pharmaceuticals industry. WEED scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. WEED is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
WEED had negative earnings in the past year.
In the past year WEED has reported a negative cash flow from operations.
In the past 5 years WEED always reported negative net income.
In the past 5 years WEED always reported negative operating cash flow.
1.2 Ratios
WEED's Return On Assets of -36.07% is on the low side compared to the rest of the industry. WEED is outperformed by 76.67% of its industry peers.
WEED's Return On Equity of -52.42% is on the low side compared to the rest of the industry. WEED is outperformed by 63.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.07% | ||
| ROE | -52.42% | ||
| ROIC | N/A |
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WEED has a Gross Margin of 27.49%. This is in the lower half of the industry: WEED underperforms 63.33% of its industry peers.
The Profit Margin and Operating Margin are not available for WEED so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
WEED does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WEED has more shares outstanding
The number of shares outstanding for WEED has been reduced compared to 5 years ago.
Compared to 1 year ago, WEED has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -8.78, we must say that WEED is in the distress zone and has some risk of bankruptcy.
WEED's Altman-Z score of -8.78 is on the low side compared to the rest of the industry. WEED is outperformed by 86.67% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that WEED is not too dependend on debt financing.
WEED's Debt to Equity ratio of 0.33 is in line compared to the rest of the industry. WEED outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -8.78 |
ROIC/WACCN/A
WACC10.09%
2.3 Liquidity
WEED has a Current Ratio of 5.50. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
WEED has a Current ratio of 5.50. This is amongst the best in the industry. WEED outperforms 96.67% of its industry peers.
WEED has a Quick Ratio of 4.23. This indicates that WEED is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.23, WEED belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.5 | ||
| Quick Ratio | 4.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 58.25% over the past year.
Looking at the last year, WEED shows a decrease in Revenue. The Revenue has decreased by -0.67% in the last year.
Measured over the past years, WEED shows a decrease in Revenue. The Revenue has been decreasing by -7.57% on average per year.
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%5.86%
3.2 Future
The Earnings Per Share is expected to grow by 15.29% on average over the next years. This is quite good.
Based on estimates for the next years, WEED will show a small growth in Revenue. The Revenue will grow by 5.39% on average per year.
EPS Next Y94.86%
EPS Next 2Y40.65%
EPS Next 3Y25.5%
EPS Next 5Y15.29%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y4.75%
Revenue Next 5Y5.39%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
WEED reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WEED. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
WEED's earnings are expected to grow with 25.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.65%
EPS Next 3Y25.5%
5. Dividend
5.1 Amount
WEED does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:WEED (12/16/2025, 7:00:00 PM)
2.53
+0.23 (+10%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners10.93%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap932.20M
Revenue(TTM)278.61M
Net Income(TTM)-385.85M
Analysts47.69
Price Target3.77 (49.01%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)51.01%
Min EPS beat(2)8.22%
Max EPS beat(2)93.8%
EPS beat(4)2
Avg EPS beat(4)-51.44%
Min EPS beat(4)-206.63%
Max EPS beat(4)93.8%
EPS beat(8)2
Avg EPS beat(8)-152.68%
EPS beat(12)3
Avg EPS beat(12)-166.46%
EPS beat(16)4
Avg EPS beat(16)-163.73%
Revenue beat(2)1
Avg Revenue beat(2)0.9%
Min Revenue beat(2)-7.76%
Max Revenue beat(2)9.57%
Revenue beat(4)3
Avg Revenue beat(4)3.88%
Min Revenue beat(4)-7.76%
Max Revenue beat(4)9.57%
Revenue beat(8)5
Avg Revenue beat(8)2.85%
Revenue beat(12)6
Avg Revenue beat(12)1.1%
Revenue beat(16)8
Avg Revenue beat(16)-0.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)66.67%
EPS NQ rev (3m)70.39%
EPS NY rev (1m)54.94%
EPS NY rev (3m)58.18%
Revenue NQ rev (1m)-8.94%
Revenue NQ rev (3m)-8.94%
Revenue NY rev (1m)-5.7%
Revenue NY rev (3m)-5.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 3.35 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.27 | ||
| P/tB | 1.54 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.81
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.76
BVpS2
TBVpS1.65
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -36.07% | ||
| ROE | -52.42% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 27.49% | ||
| FCFM | N/A |
ROA(3y)-83.37%
ROA(5y)-56.25%
ROE(3y)-219.63%
ROE(5y)-143.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 18.94% | ||
| Cap/Sales | 2.77% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.5 | ||
| Quick Ratio | 4.23 | ||
| Altman-Z | -8.78 |
F-Score5
WACC10.09%
ROIC/WACCN/A
Cap/Depr(3y)15.39%
Cap/Depr(5y)45.04%
Cap/Sales(3y)2.72%
Cap/Sales(5y)9.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.32%
EPS Next Y94.86%
EPS Next 2Y40.65%
EPS Next 3Y25.5%
EPS Next 5Y15.29%
Revenue 1Y (TTM)-0.67%
Revenue growth 3Y-19.22%
Revenue growth 5Y-7.57%
Sales Q2Q%5.86%
Revenue Next Year2.14%
Revenue Next 2Y4.71%
Revenue Next 3Y4.75%
Revenue Next 5Y5.39%
EBIT growth 1Y51.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year89.39%
EBIT Next 3Y31%
EBIT Next 5Y19.3%
FCF growth 1Y81.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.69%
OCF growth 3YN/A
OCF growth 5YN/A
CANOPY GROWTH CORP / WEED.CA FAQ
Can you provide the ChartMill fundamental rating for CANOPY GROWTH CORP?
ChartMill assigns a fundamental rating of 2 / 10 to WEED.CA.
What is the valuation status for WEED stock?
ChartMill assigns a valuation rating of 1 / 10 to CANOPY GROWTH CORP (WEED.CA). This can be considered as Overvalued.
How profitable is CANOPY GROWTH CORP (WEED.CA) stock?
CANOPY GROWTH CORP (WEED.CA) has a profitability rating of 0 / 10.